<?xml version="1.0" encoding="UTF-8"?>
<p>Considering drug repositioning to use as therapy for novel diseases is a huge advantage when the specific drugs are not yet available or developed. Among the significant challenges during the global fight against infectious diseases are the unpredictable emergence of disease and the lack of therapeutics for uncommon diseases. The most recent example is the novel coronavirus disease (COVID-19) which arose in 2019, affecting over 17,700,000 individuals worldwide [
 <xref rid="B82-viruses-12-01058" ref-type="bibr">82</xref>]. During this time, medical practitioners are at a struggle to find a rapid cure for hospitalised patients to improve patient conditions and minimise outbreak severity. Drug repurposing has been highlighted as a more effective strategy for the search of a treatment for COVID-19 as it suits the urgency for the need of treatment [
 <xref rid="B83-viruses-12-01058" ref-type="bibr">83</xref>]. 
</p>
